Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph early_phase_1
1
17%
Ph phase_1
1
17%
Ph phase_3
2
33%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Completed2
unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)

Trials by Status

recruiting117%
completed233%
terminated117%
unknown233%

Recent Activity

1 active trials
Showing 5 of 6
completedphase_1

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

NCT03524235
terminatedphase_2

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

NCT03088709
recruitingphase_3

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

NCT05392894
completedphase_3

Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

NCT02566395
unknownearly_phase_1

Haploidentical Stem Cell Transplantation in Neuroblastoma

NCT00790413
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03524235Phase 1

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

Completed
NCT03088709Phase 2

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

Terminated
NCT05392894Phase 3

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

Recruiting
NCT02566395Phase 3

Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

Completed
NCT00790413Early Phase 1

Haploidentical Stem Cell Transplantation in Neuroblastoma

Unknown
NCT02759822

Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

Unknown

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6